Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Judge Hears Landmark Hemp-Marijuana Challenge to Medicare Medicaid Reimbursing Payment Program
Healthcare & PharmaceuticalCompany Update

Judge Hears Landmark Hemp-Marijuana Challenge to Medicare Medicaid Reimbursing Payment Program

May 2, 2026 12:15 PM

A federal district court judge in Washington, D.C. signaled significant concern Friday over whether the Centers for Medicare & Medicaid Services (CMS) exceeded its statutory authority when it launched a hemp-marijuana incentive program reimbursing cannabinoid products for Medicare beneficiaries without public rule making or FDA involvement. The program took effect on April 1, 2026. The challenge, Smart Approaches to Marijuana v. Kennedy, Civil...

Read more
Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

May 1, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its manufacturing partner, Dalton Pharma Services ("Dalton"), has advanced into the next phase of intermediate-scale process development and scale-up for the Company's proprietary PNKP inhibitor technology. This next phase of work includes an expanded scale-up of precursor A83 to approximately 1,560 grams and...

Read more
Queue Ventures Announces Results of its Annual General and Special Meeting in Connection with Previously Announced Plan of Arrangement with Custom Health, Inc.
Healthcare & PharmaceuticalCompany Update

Queue Ventures Announces Results of its Annual General and Special Meeting in Connection with Previously Announced Plan of Arrangement with Custom Health, Inc.

May 1, 2026 12:40 PM

Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce the results of its annual general and special meeting of holders ("Shareholders") of common shares of the Company held on April 30, 2026 (the "Meeting"). Shareholders voted in favour of all resolutions presented at the Meeting, including the Company's previously announced plan of arrangement (the "Arrangement") with Custom Health, Inc. ("Custom Health"). As disclosed in the...

Read more
AI-Enabled Telehealth Access Through Independent Pharmacies
Healthcare & PharmaceuticalPartnerships

AI-Enabled Telehealth Access Through Independent Pharmacies

May 1, 2026 11:45 AM

Independent Pharmacy Cooperative (IPC) announces a strategic partnership with Doctronic to help independent pharmacies expand access to AI‐enabled telehealth. Building on IPC's Digital Health investments, this collaboration supports care models that prioritize convenience, speed, and trusted support close to home, while keeping pharmacies central to the patient relationship. Through this partnership, IPC and Doctronic will offer member...

Read more
Medical Care Technologies (OTC:MDCE) Targets $100K Per Client with Real Game Used Disruptive AI Platform
Healthcare & PharmaceuticalProduct Announcements

Medical Care Technologies (OTC:MDCE) Targets $100K Per Client with Real Game Used Disruptive AI Platform

May 1, 2026 9:30 AM

Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced continued advancement of its subsidiary Real Game Used's ("RGU") patent-pending artificial intelligence authentication platform, which the Company is positioning as a high-value solution for the sports memorabilia industry with a targeted offering of approximately $100,000 per client for enterprise-level access. This disruptive authentication process is anticipated to...

Read more
MIB Agents Marks 10th Anniversary with National Day of Giving to Accelerate Osteosarcoma Breakthroughs
Healthcare & PharmaceuticalCompany Update

MIB Agents Marks 10th Anniversary with National Day of Giving to Accelerate Osteosarcoma Breakthroughs

May 1, 2026 9:00 AM

For nearly 50 years, treatment options for osteosarcoma, a rare form of bone cancer that primarily affects children and young adults, have seen little meaningful advancement. Today, on its 10th anniversary, MIB Agents is launching a nationwide Day of Giving to help break that cycle. By partnering with patients, families, researchers, clinicians, and industry stakeholders, the nonprofit is working to transform the landscape of this disease and...

Read more
Tom Valentine Named President of WellBridge Surgical
Healthcare & PharmaceuticalCompany Update

Tom Valentine Named President of WellBridge Surgical

May 1, 2026 9:00 AM

WellBridge Surgical is pleased to announce the appointment of Tom Valentine as President, effective April 28, 2026. Valentine brings more than 30 years of leadership experience, with a proven track record of building high-performing teams, fostering strong partnerships, and driving sustained organizational growth. Throughout his career, Valentine has developed a reputation for combining strategic vision with hands-on leadership. His experience...

Read more
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings
Healthcare & PharmaceuticalCompany Update

Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings

May 1, 2026 8:00 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the first quarter ended March 31, 2026 after market close on Tuesday, May 12, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a...

Read more
Securitas Healthcare Acquires ZulaFly(TM) to Advance Cloud-Based RTLS and Accelerate Innovation Across Healthcare
Healthcare & PharmaceuticalMergers and Acquisitions

Securitas Healthcare Acquires ZulaFly(TM) to Advance Cloud-Based RTLS and Accelerate Innovation Across Healthcare

May 1, 2026 8:00 AM

Securitas Healthcare, a leading provider of real‑time visibility and protection solutions for the healthcare industry, is proud to announce the acquisition of ZulaFly, a healthcare‑focused Real‑Time Location System (RTLS) and staff safety technology company known for its modern, cloud‑based platform. ZulaFly's cloud-based RTLS platform delivers real-time visibility and actionable insights through a flexible, data-driven architecture. Built as a...

Read more
°MEQU Eliminates a Critical Break in Trauma Care with FDA Clearance of °M Station
Healthcare & PharmaceuticalProduct Announcements

°MEQU Eliminates a Critical Break in Trauma Care with FDA Clearance of °M Station

May 1, 2026 7:45 AM

°MEQU today announced that its °M Station has received clearance from the U.S. Food and Drug Administration, marking a major step forward in trauma care by enabling uninterrupted blood and IV fluid warming from the point of injury through hospital treatment. In trauma care, seconds matter, and so does continuity. With the °M Warmer System, there is no device swap and no lost time. Just consistent temperature management from start to finish....

Read more
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
Healthcare & PharmaceuticalEarnings

Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

May 1, 2026 6:30 AM

Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the first quarter of 2026. "The Moderna team delivered a great start to the year, driving significant revenue growth and substantial cost reductions building on actions taken in 2025. We received two product approvals in Europe, including the world's first flu plus COVID combination vaccine, mCOMBRIAX. We also started a new pivotal trial for...

Read more
What Is the Best Online Botox Course?
Healthcare & PharmaceuticalAdvertorial

What Is the Best Online Botox Course?

May 1, 2026 6:00 AM

As demand for aesthetic medicine training continues to grow, licensed medical professionals are comparing online Botox courses based on curriculum, instructor experience, continuing education value and access to practical clinical exposure. Among available online training options, the American Academy of Cosmetic Medicine (AACM), has emerged as a leading choice for eligible providers seeking structured online Botox and filler education for only...

Read more
SMILE-FX(R) Launches AI Braces(TM) System, Bringing Predictive Treatment Planning to South Florida
Healthcare & PharmaceuticalCompany Update

SMILE-FX(R) Launches AI Braces(TM) System, Bringing Predictive Treatment Planning to South Florida

May 1, 2026 2:40 AM

SMILE-FX® Orthodontic Studio has officially launched its AI Braces™ system, a proprietary orthodontic treatment approach that integrates artificial intelligence with high-resolution 3D CBCT (Cone Beam Computed Tomography) imaging to create fully mapped treatment plans from day one. The SMILE-FX® AI Braces™ System represents a departure from conventional orthodontic workflows, where treatment adjustments are often made reactively based on...

Read more
GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Healthcare & PharmaceuticalEarnings

GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results

April 30, 2026 8:55 PM

GLG Life Tech Corporation (NEX:GLG.H) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and twelve months ended December 31, 2025. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com. FINANCIAL SUMMARY The Company...

Read more
Suncoast Skin Solutions Founder Dr. Christopher Ewanowski to Lead Free Skin Cancer Screenings with BayCare on Melanoma Monday
Healthcare & PharmaceuticalCompany Update

Suncoast Skin Solutions Founder Dr. Christopher Ewanowski to Lead Free Skin Cancer Screenings with BayCare on Melanoma Monday

April 30, 2026 6:45 PM

Suncoast Skin Solutions and BayCare Health System will offer free skin cancer screenings at four Tampa Bay hospitals on May 4 in recognition of Melanoma Monday. The screenings are led by Suncoast Skin Solutions founder Dr. Christopher Ewanowski. The announcement follows Dr. Ewanowski's April 9 session at the Florida Society of Dermatology Physician Assistants (FSDPA), where he taught on clinical and surgical techniques grounded in Mohs surgery...

Read more
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
Healthcare & PharmaceuticalEarnings

Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results

April 30, 2026 4:00 PM

PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026. The Company also filed its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2026 with the Securities and Exchange Commission today. Quarter Ended March 31, 2026 Net sales for the three months ended March 31, 2026, increased $2.5 million, or 15%, to $19.9 million from $17.4 million for the three months ended...

Read more
WEED, Inc. (OTCQB:BUDZ) Unveils 2026 Growth Vision Combining Cannabis Operations, Proprietary Genetics, and Digital Asset Innovation
Healthcare & PharmaceuticalCompany Update

WEED, Inc. (OTCQB:BUDZ) Unveils 2026 Growth Vision Combining Cannabis Operations, Proprietary Genetics, and Digital Asset Innovation

April 30, 2026 3:00 PM

2026 WEED, Inc. (OTCQB:BUDZ), a publicly traded cannabis and hemp development company, today announced its updated strategic growth initiative focused on building an integrated platform spanning cannabis cultivation, manufacturing, retail expansion, proprietary strain genetics, and blockchain-enabled payment ecosystems. The Company has prepared an investor presentation that outlines a long-term vision to position BUDZ as a diversified...

Read more
Medical Component Specialists to Support Advanced Catheter Innovation at The Catheter R&D Masterclass in Ireland
Healthcare & PharmaceuticalCompany Update

Medical Component Specialists to Support Advanced Catheter Innovation at The Catheter R&D Masterclass in Ireland

April 30, 2026 1:00 PM

Medical Component Specialists (MCS), a premier manufacturer of precision medical components, today announced its participation as a supporting organization at The Catheter R&D Masterclass. Hosted by Eyedea Medtech, the highly anticipated event will take place May 28-29, 2026, at the Prototyping and Education Facility in Westport, Mayo, Ireland. The Catheter Systems Lab is an exclusive, dual-purpose educational program designed for senior...

Read more
Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months
Healthcare & PharmaceuticalCompany Update

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

April 30, 2026 12:50 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it is projecting Cur18™ to generate over $2.5 million in incremental annual revenue in the United States within the next 12 to 18 months, based on its current commercialization strategy and internal assumptions. Cur18™ is part of the Company's recently introduced "18 Series," a portfolio of...

Read more
Hemogenyx Pharmaceuticals PLC Announces Final Results
Healthcare & PharmaceuticalRegulatory

Hemogenyx Pharmaceuticals PLC Announces Final Results

April 30, 2026 12:25 PM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces its final audited results for the year ended 31 December 2025. The Annual Report is available to view on the Company's website at https://hemogenyx.com/. Key Highlights The Company commenced the Phase 1 clinical trial of HG-CT-1, its lead CAR-T cell therapy candidate. The independent Data Safety Monitoring...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?